 Michael Schurr
Concepts (381)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas aeruginosa | 56 | 2025 | 358 | 6.100 |
Why?
| | Gene Expression Regulation, Bacterial | 32 | 2018 | 320 | 3.860 |
Why?
| | Bacterial Proteins | 34 | 2019 | 911 | 3.200 |
Why?
| | Trans-Activators | 11 | 2018 | 388 | 2.600 |
Why?
| | Corynebacterium Infections | 6 | 2024 | 42 | 2.250 |
Why?
| | Corynebacterium | 7 | 2024 | 49 | 2.210 |
Why?
| | Pseudomonas Infections | 16 | 2025 | 230 | 1.730 |
Why?
| | Biofilms | 19 | 2021 | 271 | 1.670 |
Why?
| | Alginates | 19 | 2020 | 46 | 1.560 |
Why?
| | Sigma Factor | 16 | 2013 | 41 | 1.070 |
Why?
| | Mice, Nude | 4 | 2024 | 691 | 1.010 |
Why?
| | Transcription, Genetic | 18 | 2014 | 1487 | 1.010 |
Why?
| | Cell-Penetrating Peptides | 1 | 2025 | 22 | 0.900 |
Why?
| | Gentamicins | 1 | 2025 | 52 | 0.890 |
Why?
| | Anti-Bacterial Agents | 12 | 2025 | 1865 | 0.890 |
Why?
| | Cystic Fibrosis | 19 | 2020 | 1126 | 0.870 |
Why?
| | Regulon | 5 | 2014 | 36 | 0.780 |
Why?
| | Urinary Tract Infections | 1 | 2025 | 194 | 0.760 |
Why?
| | Drug Delivery Systems | 1 | 2025 | 361 | 0.710 |
Why?
| | Lasers, Solid-State | 1 | 2021 | 23 | 0.700 |
Why?
| | Titanium | 1 | 2021 | 85 | 0.670 |
Why?
| | Transcription Factors | 10 | 2014 | 1703 | 0.590 |
Why?
| | Pyocyanine | 1 | 2018 | 2 | 0.570 |
Why?
| | Protein Processing, Post-Translational | 2 | 2018 | 464 | 0.550 |
Why?
| | Staphylococcus aureus | 2 | 2023 | 437 | 0.520 |
Why?
| | Genes, Bacterial | 15 | 2010 | 166 | 0.490 |
Why?
| | Oligopeptides | 1 | 2018 | 266 | 0.490 |
Why?
| | Nitrites | 6 | 2021 | 89 | 0.460 |
Why?
| | Mice | 22 | 2025 | 18048 | 0.450 |
Why?
| | Promoter Regions, Genetic | 11 | 2014 | 1242 | 0.420 |
Why?
| | Quorum Sensing | 5 | 2016 | 74 | 0.410 |
Why?
| | Mice, Inbred NOD | 4 | 2023 | 600 | 0.400 |
Why?
| | Glycolipids | 1 | 2013 | 44 | 0.400 |
Why?
| | Bacteria | 4 | 2020 | 881 | 0.390 |
Why?
| | Culture Media | 5 | 2024 | 163 | 0.390 |
Why?
| | Locomotion | 1 | 2013 | 106 | 0.380 |
Why?
| | Gene Expression Profiling | 10 | 2018 | 1764 | 0.380 |
Why?
| | Virulence | 10 | 2018 | 268 | 0.370 |
Why?
| | Molecular Sequence Data | 19 | 2014 | 2929 | 0.350 |
Why?
| | Composite Resins | 2 | 2021 | 107 | 0.340 |
Why?
| | Edetic Acid | 2 | 2021 | 50 | 0.330 |
Why?
| | Heat-Shock Response | 3 | 2013 | 77 | 0.330 |
Why?
| | Animals | 27 | 2025 | 37657 | 0.330 |
Why?
| | Coinfection | 2 | 2023 | 137 | 0.330 |
Why?
| | Base Sequence | 15 | 2014 | 2180 | 0.320 |
Why?
| | Disinfectants | 2 | 2021 | 46 | 0.320 |
Why?
| | Oligonucleotide Array Sequence Analysis | 6 | 2013 | 761 | 0.300 |
Why?
| | DNA-Binding Proteins | 5 | 2009 | 1478 | 0.300 |
Why?
| | Hexosyltransferases | 2 | 2010 | 6 | 0.300 |
Why?
| | Epithelial Cells | 3 | 2006 | 1110 | 0.290 |
Why?
| | Cryoprotective Agents | 1 | 2008 | 10 | 0.290 |
Why?
| | Cyanides | 1 | 2009 | 53 | 0.290 |
Why?
| | Skin Diseases | 2 | 2023 | 147 | 0.280 |
Why?
| | Microbial Viability | 1 | 2008 | 91 | 0.270 |
Why?
| | Milk | 1 | 2008 | 123 | 0.270 |
Why?
| | Gene Deletion | 6 | 2013 | 388 | 0.270 |
Why?
| | Repressor Proteins | 3 | 2009 | 425 | 0.270 |
Why?
| | Cryopreservation | 1 | 2008 | 106 | 0.260 |
Why?
| | Staphylococcal Infections | 2 | 2023 | 392 | 0.260 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2021 | 199 | 0.250 |
Why?
| | Phosphorylation | 4 | 2018 | 1768 | 0.250 |
Why?
| | Mice, SCID | 2 | 2023 | 367 | 0.230 |
Why?
| | Re-Epithelialization | 3 | 2021 | 8 | 0.230 |
Why?
| | Hydrogen Cyanide | 1 | 2004 | 5 | 0.220 |
Why?
| | Disease Models, Animal | 6 | 2024 | 4404 | 0.220 |
Why?
| | Space Flight | 3 | 2010 | 93 | 0.210 |
Why?
| | Hexuronic Acids | 11 | 2014 | 23 | 0.210 |
Why?
| | Glucuronic Acid | 11 | 2014 | 25 | 0.210 |
Why?
| | Transcription Initiation Site | 3 | 2014 | 43 | 0.210 |
Why?
| | Burns | 2 | 2019 | 349 | 0.210 |
Why?
| | Lung | 5 | 2019 | 4134 | 0.210 |
Why?
| | Bacterial Adhesion | 3 | 2019 | 103 | 0.200 |
Why?
| | Respiratory System | 1 | 2004 | 157 | 0.200 |
Why?
| | Azo Compounds | 2 | 2021 | 30 | 0.190 |
Why?
| | Rodentia | 2 | 2021 | 59 | 0.190 |
Why?
| | Streptococcus mutans | 1 | 2021 | 8 | 0.180 |
Why?
| | Dental Bonding | 1 | 2021 | 29 | 0.180 |
Why?
| | Sodium Nitrite | 2 | 2020 | 39 | 0.180 |
Why?
| | Aggregatibacter actinomycetemcomitans | 1 | 2021 | 27 | 0.180 |
Why?
| | Acinetobacter Infections | 1 | 2021 | 13 | 0.170 |
Why?
| | DNA, Bacterial | 4 | 2014 | 339 | 0.170 |
Why?
| | Coated Materials, Biocompatible | 2 | 2019 | 65 | 0.170 |
Why?
| | Acinetobacter baumannii | 1 | 2021 | 21 | 0.170 |
Why?
| | Iron | 4 | 2014 | 323 | 0.170 |
Why?
| | Epidermal Growth Factor | 1 | 2021 | 176 | 0.170 |
Why?
| | Wilderness | 1 | 2020 | 16 | 0.170 |
Why?
| | Wound Infection | 1 | 2021 | 37 | 0.170 |
Why?
| | Drinking Water | 1 | 2022 | 93 | 0.170 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2021 | 79 | 0.170 |
Why?
| | Iraq War, 2003-2011 | 1 | 2021 | 140 | 0.160 |
Why?
| | Mountaineering | 1 | 2020 | 40 | 0.160 |
Why?
| | Afghan Campaign 2001- | 1 | 2021 | 153 | 0.160 |
Why?
| | Surface Properties | 1 | 2021 | 412 | 0.160 |
Why?
| | Microbial Interactions | 1 | 2020 | 18 | 0.160 |
Why?
| | Microarray Analysis | 2 | 2018 | 116 | 0.160 |
Why?
| | Chlorine Compounds | 1 | 2019 | 10 | 0.160 |
Why?
| | Skin, Artificial | 1 | 2019 | 4 | 0.160 |
Why?
| | Wound Healing | 3 | 2021 | 348 | 0.160 |
Why?
| | Decontamination | 1 | 2019 | 32 | 0.150 |
Why?
| | Oxides | 1 | 2019 | 49 | 0.150 |
Why?
| | Heat-Shock Proteins | 2 | 1997 | 142 | 0.150 |
Why?
| | Skin Transplantation | 1 | 2019 | 85 | 0.150 |
Why?
| | Metabolic Networks and Pathways | 3 | 2020 | 184 | 0.150 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2019 | 61 | 0.140 |
Why?
| | Accidental Falls | 1 | 2020 | 198 | 0.140 |
Why?
| | Mutation | 8 | 2019 | 4013 | 0.130 |
Why?
| | Amino Acid Sequence | 11 | 2011 | 2158 | 0.130 |
Why?
| | Models, Biological | 1 | 2005 | 1828 | 0.130 |
Why?
| | Operon | 2 | 2009 | 68 | 0.130 |
Why?
| | Gene Conversion | 1 | 1996 | 7 | 0.130 |
Why?
| | Humans | 31 | 2025 | 141187 | 0.130 |
Why?
| | Aspergillus | 1 | 2016 | 19 | 0.130 |
Why?
| | Age Factors | 1 | 2024 | 3292 | 0.130 |
Why?
| | Amidohydrolases | 1 | 2016 | 32 | 0.120 |
Why?
| | Polyurethanes | 1 | 2016 | 37 | 0.120 |
Why?
| | Gallium | 1 | 2015 | 5 | 0.120 |
Why?
| | Multigene Family | 4 | 1994 | 202 | 0.120 |
Why?
| | Nitric Oxide | 2 | 2014 | 900 | 0.120 |
Why?
| | Severity of Illness Index | 1 | 2024 | 2892 | 0.120 |
Why?
| | Drosophila melanogaster | 1 | 2018 | 237 | 0.120 |
Why?
| | Aspartate Carbamoyltransferase | 1 | 1995 | 3 | 0.120 |
Why?
| | Dihydroorotase | 1 | 1995 | 3 | 0.120 |
Why?
| | Intubation, Intratracheal | 1 | 2018 | 286 | 0.110 |
Why?
| | Phenotype | 9 | 2014 | 3166 | 0.110 |
Why?
| | Tissue Engineering | 1 | 2019 | 429 | 0.110 |
Why?
| | Microbial Sensitivity Tests | 4 | 2021 | 370 | 0.110 |
Why?
| | Gastrointestinal Microbiome | 1 | 2023 | 725 | 0.110 |
Why?
| | Oxidoreductases Acting on CH-NH2 Group Donors | 2 | 2004 | 2 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-sis | 1 | 2014 | 39 | 0.110 |
Why?
| | Splints | 1 | 2014 | 15 | 0.110 |
Why?
| | Multienzyme Complexes | 2 | 2004 | 66 | 0.110 |
Why?
| | Polysaccharides, Bacterial | 2 | 2014 | 70 | 0.110 |
Why?
| | Pseudomonas putida | 1 | 1995 | 38 | 0.110 |
Why?
| | Escherichia coli | 5 | 1996 | 838 | 0.110 |
Why?
| | Oxidoreductases | 2 | 2004 | 96 | 0.110 |
Why?
| | Patient Selection | 1 | 2018 | 688 | 0.110 |
Why?
| | Catalase | 1 | 2014 | 134 | 0.110 |
Why?
| | Microbiota | 1 | 2022 | 767 | 0.110 |
Why?
| | Cyclic GMP | 1 | 2014 | 91 | 0.110 |
Why?
| | Flagella | 2 | 2011 | 27 | 0.100 |
Why?
| | Host Factor 1 Protein | 2 | 2010 | 4 | 0.100 |
Why?
| | Athletic Injuries | 1 | 2020 | 522 | 0.100 |
Why?
| | Fimbriae Proteins | 1 | 2013 | 21 | 0.100 |
Why?
| | RNA Polymerase Sigma 54 | 2 | 2011 | 3 | 0.100 |
Why?
| | Vanadates | 1 | 2013 | 17 | 0.100 |
Why?
| | Mutant Proteins | 1 | 2013 | 102 | 0.100 |
Why?
| | Drug Resistance, Bacterial | 3 | 2020 | 192 | 0.100 |
Why?
| | DNA-Directed RNA Polymerases | 3 | 2000 | 63 | 0.100 |
Why?
| | Carbohydrate Dehydrogenases | 4 | 2000 | 11 | 0.100 |
Why?
| | Respiration, Artificial | 1 | 2018 | 683 | 0.100 |
Why?
| | Female | 9 | 2025 | 75515 | 0.100 |
Why?
| | Peptide Hydrolases | 1 | 2013 | 112 | 0.100 |
Why?
| | Plasmids | 3 | 2007 | 365 | 0.100 |
Why?
| | Pyruvic Acid | 1 | 2012 | 55 | 0.090 |
Why?
| | Pseudomonas Phages | 1 | 2011 | 3 | 0.090 |
Why?
| | Bacteriolysis | 1 | 2011 | 9 | 0.090 |
Why?
| | Mutation, Missense | 1 | 2013 | 339 | 0.090 |
Why?
| | Exopeptidases | 1 | 2011 | 1 | 0.090 |
Why?
| | Methacrylates | 2 | 2021 | 117 | 0.090 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2011 | 33 | 0.090 |
Why?
| | Cyclic AMP Receptor Protein | 1 | 2010 | 4 | 0.080 |
Why?
| | Weightlessness | 1 | 2010 | 48 | 0.080 |
Why?
| | Cells, Cultured | 4 | 2021 | 4208 | 0.080 |
Why?
| | Materials Testing | 2 | 2021 | 353 | 0.080 |
Why?
| | Protein Kinases | 1 | 2011 | 308 | 0.080 |
Why?
| | Cyclic AMP | 1 | 2010 | 219 | 0.080 |
Why?
| | Salmonella typhimurium | 2 | 2010 | 185 | 0.080 |
Why?
| | DNA Footprinting | 1 | 2009 | 33 | 0.080 |
Why?
| | Anaerobiosis | 4 | 2014 | 65 | 0.080 |
Why?
| | Fimbriae, Bacterial | 2 | 2010 | 34 | 0.070 |
Why?
| | Salmonella | 1 | 2008 | 63 | 0.070 |
Why?
| | Glycerol | 1 | 2008 | 91 | 0.070 |
Why?
| | Virulence Factors | 3 | 2017 | 162 | 0.070 |
Why?
| | Phosphates | 2 | 2008 | 181 | 0.070 |
Why?
| | Proteome | 2 | 2011 | 483 | 0.070 |
Why?
| | Chromosome Mapping | 3 | 1997 | 504 | 0.070 |
Why?
| | DNA, Mitochondrial | 1 | 1988 | 211 | 0.070 |
Why?
| | Polymerase Chain Reaction | 3 | 2021 | 1056 | 0.060 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 3 | 2008 | 112 | 0.060 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2019 | 556 | 0.060 |
Why?
| | Lung Diseases | 3 | 2020 | 794 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2020 | 346 | 0.060 |
Why?
| | Skin | 2 | 2021 | 765 | 0.060 |
Why?
| | Mucin-1 | 1 | 2005 | 21 | 0.060 |
Why?
| | Gene Expression | 3 | 2021 | 1491 | 0.060 |
Why?
| | Bandages | 2 | 2015 | 42 | 0.060 |
Why?
| | Collagen Type IV | 1 | 2005 | 28 | 0.060 |
Why?
| | Laminin | 1 | 2005 | 72 | 0.060 |
Why?
| | Single-Strand Specific DNA and RNA Endonucleases | 1 | 2004 | 10 | 0.060 |
Why?
| | Mucin 5AC | 1 | 2005 | 70 | 0.060 |
Why?
| | Bioreactors | 1 | 2005 | 48 | 0.050 |
Why?
| | Sequence Alignment | 3 | 2011 | 363 | 0.050 |
Why?
| | Tissue Culture Techniques | 1 | 2024 | 82 | 0.050 |
Why?
| | Mucins | 1 | 2005 | 73 | 0.050 |
Why?
| | Electron Transport Complex IV | 1 | 2004 | 62 | 0.050 |
Why?
| | Down-Regulation | 2 | 2020 | 641 | 0.050 |
Why?
| | Amoxicillin | 1 | 2023 | 35 | 0.050 |
Why?
| | Contact Lenses, Hydrophilic | 1 | 2003 | 7 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 2 | 1996 | 672 | 0.050 |
Why?
| | Interleukins | 1 | 2005 | 248 | 0.050 |
Why?
| | Phosphotransferases (Phosphomutases) | 1 | 2002 | 5 | 0.050 |
Why?
| | Hypochlorous Acid | 1 | 2002 | 8 | 0.050 |
Why?
| | Animal Husbandry | 1 | 2023 | 37 | 0.050 |
Why?
| | Antigens | 1 | 2005 | 362 | 0.050 |
Why?
| | Glucose Oxidase | 1 | 2002 | 26 | 0.050 |
Why?
| | Ammonia | 1 | 2023 | 61 | 0.050 |
Why?
| | Glycoproteins | 1 | 2005 | 356 | 0.050 |
Why?
| | Sanitation | 1 | 2023 | 55 | 0.050 |
Why?
| | Housing, Animal | 1 | 2023 | 46 | 0.050 |
Why?
| | Genotype | 1 | 2007 | 1859 | 0.050 |
Why?
| | Cell Culture Techniques | 1 | 2005 | 368 | 0.050 |
Why?
| | Antigens, Neoplasm | 1 | 2005 | 321 | 0.050 |
Why?
| | Movement | 1 | 2004 | 289 | 0.050 |
Why?
| | Peroxidase | 1 | 2002 | 182 | 0.050 |
Why?
| | Dentistry | 1 | 2021 | 11 | 0.050 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2013 | 136 | 0.050 |
Why?
| | Dentin | 1 | 2021 | 22 | 0.050 |
Why?
| | Dentin-Bonding Agents | 1 | 2021 | 16 | 0.050 |
Why?
| | Dental Cements | 1 | 2021 | 20 | 0.050 |
Why?
| | Adaptation, Physiological | 2 | 2004 | 560 | 0.050 |
Why?
| | Protein Binding | 3 | 2014 | 2239 | 0.050 |
Why?
| | Bisphenol A-Glycidyl Methacrylate | 1 | 2021 | 54 | 0.050 |
Why?
| | Tensile Strength | 1 | 2021 | 97 | 0.040 |
Why?
| | Pneumonia, Bacterial | 2 | 2013 | 117 | 0.040 |
Why?
| | Dental Materials | 1 | 2021 | 57 | 0.040 |
Why?
| | Iraq | 1 | 2021 | 58 | 0.040 |
Why?
| | Afghanistan | 1 | 2021 | 79 | 0.040 |
Why?
| | Amoxicillin-Potassium Clavulanate Combination | 1 | 2020 | 16 | 0.040 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2020 | 60 | 0.040 |
Why?
| | Signal Transduction | 4 | 2010 | 5144 | 0.040 |
Why?
| | Bacterial Capsules | 2 | 2002 | 31 | 0.040 |
Why?
| | Bacteremia | 1 | 2002 | 216 | 0.040 |
Why?
| | Mutagenesis, Insertional | 4 | 2008 | 65 | 0.040 |
Why?
| | Drug Combinations | 1 | 2021 | 358 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2005 | 1250 | 0.040 |
Why?
| | Mucus | 2 | 2006 | 78 | 0.040 |
Why?
| | Random Allocation | 1 | 2020 | 367 | 0.040 |
Why?
| | Plankton | 1 | 2019 | 7 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2022 | 557 | 0.040 |
Why?
| | Dermis | 1 | 2019 | 34 | 0.040 |
Why?
| | Intention to Treat Analysis | 1 | 2019 | 76 | 0.040 |
Why?
| | Gases | 1 | 2019 | 50 | 0.040 |
Why?
| | Pruritus | 1 | 2019 | 64 | 0.040 |
Why?
| | Chlorine | 1 | 2019 | 64 | 0.040 |
Why?
| | Equipment Contamination | 1 | 2019 | 71 | 0.040 |
Why?
| | Osmolar Concentration | 2 | 1997 | 167 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 987 | 0.040 |
Why?
| | Immunocompromised Host | 1 | 2020 | 203 | 0.040 |
Why?
| | Epidermis | 1 | 2019 | 157 | 0.040 |
Why?
| | Salvage Therapy | 1 | 2019 | 153 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2019 | 280 | 0.040 |
Why?
| | Consciousness Disorders | 1 | 2018 | 20 | 0.040 |
Why?
| | Injury Severity Score | 1 | 2020 | 559 | 0.040 |
Why?
| | Soot | 1 | 2018 | 26 | 0.030 |
Why?
| | Proteomics | 3 | 2010 | 1134 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2020 | 863 | 0.030 |
Why?
| | Facial Injuries | 1 | 2018 | 23 | 0.030 |
Why?
| | Hypercapnia | 1 | 2018 | 54 | 0.030 |
Why?
| | Smoke Inhalation Injury | 1 | 2018 | 30 | 0.030 |
Why?
| | Trauma Centers | 1 | 2020 | 447 | 0.030 |
Why?
| | Respiratory Sounds | 1 | 2018 | 109 | 0.030 |
Why?
| | Edema | 1 | 2018 | 131 | 0.030 |
Why?
| | Adhesins, Bacterial | 2 | 2010 | 40 | 0.030 |
Why?
| | Cloning, Molecular | 2 | 1995 | 533 | 0.030 |
Why?
| | Mice, Inbred BALB C | 2 | 2011 | 1274 | 0.030 |
Why?
| | Laryngoscopy | 1 | 2018 | 115 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1490 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2024 | 3469 | 0.030 |
Why?
| | Mutagenesis | 2 | 1994 | 182 | 0.030 |
Why?
| | Adult | 4 | 2021 | 39177 | 0.030 |
Why?
| | Drosophila | 1 | 2017 | 154 | 0.030 |
Why?
| | Male | 6 | 2020 | 69783 | 0.030 |
Why?
| | Periplasmic Proteins | 1 | 1996 | 4 | 0.030 |
Why?
| | Deglutition Disorders | 1 | 2018 | 148 | 0.030 |
Why?
| | Sulfur Radioisotopes | 1 | 1995 | 15 | 0.030 |
Why?
| | Polyvinyl Alcohol | 1 | 2015 | 18 | 0.030 |
Why?
| | Chemical Precipitation | 1 | 1995 | 39 | 0.030 |
Why?
| | Open Reading Frames | 1 | 1996 | 132 | 0.030 |
Why?
| | Electrolytes | 1 | 2015 | 56 | 0.030 |
Why?
| | Fibroblasts | 1 | 2021 | 1020 | 0.030 |
Why?
| | Chronic Disease | 2 | 2019 | 1816 | 0.030 |
Why?
| | Biomass | 1 | 2015 | 113 | 0.030 |
Why?
| | DNA Primers | 1 | 1996 | 510 | 0.030 |
Why?
| | Solubility | 1 | 2015 | 245 | 0.030 |
Why?
| | Isotope Labeling | 1 | 1995 | 81 | 0.030 |
Why?
| | Odds Ratio | 1 | 2018 | 1052 | 0.030 |
Why?
| | Serine Endopeptidases | 1 | 1996 | 119 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 2086 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 4 | 1997 | 391 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2015 | 177 | 0.030 |
Why?
| | Genes, Suppressor | 1 | 1994 | 4 | 0.030 |
Why?
| | RNA, Bacterial | 1 | 1995 | 190 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2020 | 868 | 0.030 |
Why?
| | Rats | 1 | 2023 | 5629 | 0.030 |
Why?
| | Lethal Dose 50 | 2 | 2008 | 15 | 0.030 |
Why?
| | Nitrogen Oxides | 1 | 2014 | 54 | 0.030 |
Why?
| | Agar | 1 | 2013 | 11 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2794 | 0.030 |
Why?
| | Biomarkers | 1 | 2005 | 4174 | 0.030 |
Why?
| | Temperature | 1 | 1996 | 669 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2014 | 274 | 0.020 |
Why?
| | Escherichia coli Proteins | 1 | 1995 | 201 | 0.020 |
Why?
| | United States | 2 | 2021 | 15220 | 0.020 |
Why?
| | Middle Aged | 3 | 2020 | 34434 | 0.020 |
Why?
| | Keratinocytes | 1 | 2014 | 252 | 0.020 |
Why?
| | Reactive Oxygen Species | 4 | 1997 | 630 | 0.020 |
Why?
| | Drug Tolerance | 1 | 2013 | 105 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2014 | 194 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2013 | 117 | 0.020 |
Why?
| | Immunoblotting | 1 | 2013 | 310 | 0.020 |
Why?
| | Fermentation | 1 | 2012 | 30 | 0.020 |
Why?
| | Young Adult | 2 | 2020 | 13673 | 0.020 |
Why?
| | Kinetics | 1 | 2015 | 1652 | 0.020 |
Why?
| | Histidine Kinase | 1 | 2011 | 33 | 0.020 |
Why?
| | Collagen | 1 | 2014 | 459 | 0.020 |
Why?
| | Genetic Variation | 1 | 1997 | 1000 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2002 | 5887 | 0.020 |
Why?
| | Viral Plaque Assay | 1 | 2011 | 34 | 0.020 |
Why?
| | Denitrification | 1 | 2010 | 5 | 0.020 |
Why?
| | Transcriptome | 1 | 2017 | 1003 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2020 | 16273 | 0.020 |
Why?
| | Ecological Systems, Closed | 1 | 2010 | 5 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 1994 | 1357 | 0.020 |
Why?
| | Lectins | 1 | 2010 | 46 | 0.020 |
Why?
| | Hypoxia | 1 | 2018 | 1164 | 0.020 |
Why?
| | Acute Disease | 1 | 2013 | 1008 | 0.020 |
Why?
| | Salmonella enterica | 1 | 2010 | 57 | 0.020 |
Why?
| | Adolescent | 2 | 2020 | 22007 | 0.020 |
Why?
| | Oxidative Stress | 1 | 1996 | 1330 | 0.020 |
Why?
| | 4-Butyrolactone | 1 | 2009 | 22 | 0.020 |
Why?
| | Oleic Acid | 1 | 2009 | 42 | 0.020 |
Why?
| | DNA Restriction Enzymes | 1 | 1988 | 51 | 0.020 |
Why?
| | Ions | 1 | 2008 | 67 | 0.020 |
Why?
| | Electrophoresis, Agar Gel | 1 | 1988 | 25 | 0.020 |
Why?
| | Membrane Proteins | 1 | 1995 | 1154 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2020 | 2172 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2009 | 377 | 0.020 |
Why?
| | Bacteriophage Pf1 | 1 | 2008 | 2 | 0.020 |
Why?
| | Weightlessness Simulation | 1 | 2007 | 7 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2008 | 145 | 0.020 |
Why?
| | RNA, Messenger | 1 | 1995 | 2828 | 0.020 |
Why?
| | Models, Molecular | 1 | 1993 | 1603 | 0.020 |
Why?
| | Salmonella Infections, Animal | 1 | 2007 | 38 | 0.020 |
Why?
| | Nitrates | 1 | 2008 | 97 | 0.020 |
Why?
| | Pregnancy | 1 | 2020 | 7070 | 0.020 |
Why?
| | Spectrum Analysis | 1 | 2007 | 92 | 0.020 |
Why?
| | DNA Transposable Elements | 1 | 2008 | 120 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2009 | 859 | 0.020 |
Why?
| | Molecular Weight | 2 | 1997 | 329 | 0.020 |
Why?
| | Oxygen | 1 | 2010 | 993 | 0.010 |
Why?
| | Viral Proteins | 1 | 2008 | 369 | 0.010 |
Why?
| | Genetic Complementation Test | 2 | 1995 | 66 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2019 | 11120 | 0.010 |
Why?
| | Sputum | 1 | 2006 | 309 | 0.010 |
Why?
| | Neutrophils | 1 | 2010 | 1282 | 0.010 |
Why?
| | Hot Temperature | 2 | 1997 | 403 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2011 | 3068 | 0.010 |
Why?
| | Morphogenesis | 2 | 1994 | 171 | 0.010 |
Why?
| | Colony Count, Microbial | 1 | 2003 | 123 | 0.010 |
Why?
| | Respiratory Mucosa | 1 | 2006 | 330 | 0.010 |
Why?
| | Electric Impedance | 1 | 2003 | 111 | 0.010 |
Why?
| | Proteins | 1 | 1988 | 1010 | 0.010 |
Why?
| | Sequence Analysis, DNA | 2 | 1997 | 824 | 0.010 |
Why?
| | Cell Wall | 1 | 2002 | 60 | 0.010 |
Why?
| | Bacterial Toxins | 1 | 2002 | 104 | 0.010 |
Why?
| | Bacterial Infections | 1 | 2002 | 245 | 0.010 |
Why?
| | Polymers | 1 | 2003 | 491 | 0.010 |
Why?
| | Nitrogen | 1 | 2000 | 165 | 0.010 |
Why?
| | Lipopolysaccharides | 1 | 2002 | 889 | 0.010 |
Why?
| | Aged | 1 | 2018 | 24574 | 0.010 |
Why?
| | Sodium Chloride | 1 | 1997 | 140 | 0.010 |
Why?
| | Suppression, Genetic | 1 | 1996 | 24 | 0.010 |
Why?
| | Transformation, Bacterial | 1 | 1995 | 9 | 0.010 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1993 | 143 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 1993 | 206 | 0.010 |
Why?
| | Models, Genetic | 1 | 1994 | 591 | 0.010 |
Why?
| | Infant | 1 | 2006 | 9818 | 0.010 |
Why?
| | Child, Preschool | 1 | 2006 | 11457 | 0.010 |
Why?
| | Alleles | 1 | 1993 | 891 | 0.010 |
Why?
| | Respiratory Tract Infections | 1 | 1993 | 385 | 0.000 |
Why?
| | Child | 1 | 2006 | 22308 | 0.000 |
Why?
|
|
Schurr's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|